Nexus Biopharma Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$771.6 K |
Shares Outstanding |
64.3 M |
Public Float |
40.87 M |
Address |
8 Hillside Avenue Montclair New Jersey 07042 United States |
Employees | - |
Website | http://www.nexusbiopharma.com |
Updated | 07/08/2019 |
Nexus Biopharma, Inc. is a preclinical stage biotechnology company developing new therapies and intellectual property for research and development activities for treating obesity and type 2 diabetes. The company was founded on July 17, 2007 and is headquartered in Montclair, New Jersey. . |